Vanda Pharmaceuticals DSO Ratio 2011-2025 | VNDA

Annual DSO Ratio Vanda Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
74.6	64.1	47.3	42.5	41.5	42.4	54.4	38.9	50.7	54.2	26.6	23.3	16.1	18.9

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
74.6	16.1	42.5

Quarterly DSO Ratio Vanda Pharmaceuticals

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
77.7	83.6	-	81	-	-	-	73.9	57.6	42.4	-	20.5	21.6	47.7	-	51.1	46.1	44.8	40.5	45.5	44.1	44.4	39.5	40.5	40.7	52.7	49.5	53.5	55.5	48.5	36.3	38.9	38.2	46.2	48.4	48.1	51.3	50.2	46.8	52.6	54	41.2	21.7	22.6	30.7	28.4	21.1	21.3	22.3	18.1	13.5	12.9	12.7	15.6	17.6	18.5	19.9	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
83.6	12.7	40.2

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	31.5	$ 4.85	3.03 %	$ 805 M	Canada
Aclaris Therapeutics ACRS	6.01	$ 3.24	-0.46 %	$ 250 M	USA
Aptevo Therapeutics APVO	79	$ 1.06	-6.19 %	$ 293 K	USA
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 216.6	-1.74 %	$ 5 B	Danmark
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.14	-4.56 %	$ 7.55 B	Australia
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Amphastar Pharmaceuticals AMPH	62.6	$ 26.28	3.99 %	$ 1.27 B	USA
Anika Therapeutics ANIK	77.3	$ 9.56	-	$ 140 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 0.27	-7.19 %	$ 588 M	Israel
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	22.6	-	3.77 %	$ 22.4 M	USA
Catalyst Biosciences CBIO	3.24	$ 13.75	-2.41 %	$ 905 M	USA
Axon Enterprise AXON	134	$ 545.68	-3.3 %	$ 41.3 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	150	$ 2.37	3.04 %	$ 14.9 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	169	$ 11.36	-1.52 %	$ 735 M	USA
Biogen BIIB	57.9	$ 173.96	-0.08 %	$ 25.3 B	USA
Abeona Therapeutics ABEO	387	$ 5.09	-5.13 %	$ 109 M	USA
Celldex Therapeutics CLDX	86.5	$ 27.29	-0.8 %	$ 1.76 M	USA
ADiTx Therapeutics ADTX	621	$ 1.65	-26.34 %	$ 21.7 K	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Фармсинтез LIFE	209	-	-	-	Russia